Evaluating the measurement properties of patient-reported outcome measures in radiotherapy-induced xerostomia.


Journal

Oral diseases
ISSN: 1601-0825
Titre abrégé: Oral Dis
Pays: Denmark
ID NLM: 9508565

Informations de publication

Date de publication:
Jul 2021
Historique:
revised: 06 05 2020
received: 07 01 2020
accepted: 07 05 2020
pubmed: 18 5 2020
medline: 16 6 2021
entrez: 18 5 2020
Statut: ppublish

Résumé

Radiotherapy-induced xerostomia (RIX) is one of the most common adverse effects of radiotherapy to the head and neck, and a major determinant of survivors' quality of life. A number of patient-reported outcome measures (PROMs) have been used in clinical trials of therapeutic interventions for RIX; however, little is known regarding their measurement properties and methodological quality. We conducted a systematic literature search in Embase, MEDLINE and PsycINFO for articles published up to May 2019 and evaluating at least one measurement property of PROMs relevant to RIX. The COSMIN guidelines were used to assess relevant measurement properties and methodological quality. Nine validations studies were identified reporting on four PROMs relevant to RIX. The Xerostomia Questionnaire (XQ) showed overall high-quality evidence for structural validity and internal consistency, but low-quality evidence supporting reliability. The methodological quality of the Groningen Radiotherapy-Induced Xerostomia scale (GRIX), Xerostomia Inventory (XI) and the Xerostomia Quality of Life Scale (XeQoLS) was relatively low for all measurement properties. The XQ was found to have the highest potential to capture changes in RIX according to COSMIN guidelines. Additional validation studies are required to further understand the methodological quality of the XI, GRIX and XeQoLS.

Identifiants

pubmed: 32418292
doi: 10.1111/odi.13416
doi:

Types de publication

Journal Article Review Systematic Review

Langues

eng

Pagination

1097-1105

Subventions

Organisme : Department of Health
ID : PB-PG-0909-20063
Pays : United Kingdom

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. All rights reserved.

Références

Allen, I., & Seaman, C. (2007). Likert scales and data analyses. Quality Progress, 40(7), 64-65.
Beetz, I., Burlage, F. R., Bijl, H. P., Hoegen-Chouvalova, O., Christianen, M. E. M. C., Vissink, A., … Langendijk, J. A. (2010). The Groningen Radiotherapy-Induced Xerostomia questionnaire: Development and validation of a new questionnaire. Radiotherapy and Oncology, 97(1), 127-131. https://doi.org/10.1016/j.radonc.2010.05.004
Duke, R. L., Campbell, B. H., Schultz, C. J., Marbella, A., Myers, K. B., & Layde, P. (2004). Xerostomia and effects on quality of life in long-term head and neck cancer survivors. Otolaryngology - Head and Neck Surgery, 131(2), P183-P184. https://doi.org/10.1016/j.otohns.2004.06.334
Eisbruch, A., Kim, H. M., Terrell, J. E., Marsh, L. H., Dawson, L. A., & Ship, J. A. (2001). Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. International Journal of Radiation Oncology Biology Physics, 50(3), 695-704. https://doi.org/10.1016/S0360-3016(01)01512-7
Eisbruch, A., Rhodus, N., Rosenthal, D., Murphy, B., Rasch, C., Sonis, S., … Brizel, D. (2003). The prevention and treatment of radiotherapy-induced xerostomia. Seminars in Radiation Oncology, 13(3), 302-308. https://doi.org/10.1016/S1053-4296(03)00027-4
Fang, F. M., Liu, Y. T., Tang, Y., Wang, C. J., & Ko, S. F. (2004). Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer, 100(2), 425-432. https://doi.org/10.1002/cncr.20010
Hawkins, P. G., Lee, J. Y., Mao, Y., Li, P., Worden, F., Swiecicki, P. L., … Eisbruch, A. (2018). Sparing All Salivary Glands With IMRT for Head and Neck Cancer: Longitudinal Study of Patient-Reported Xerostomia and Head and Neck Quality Of Life. International Journal of Radiation Oncology Biology Physics, 100(5), 1388-1389. https://doi.org/10.1016/j.ijrobp.2017.12.210
Henson, B. S., Inglehart, M. R., Eisbruch, A., & Ship, J. A. (2001). Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncology, 37(1), 84-93. https://doi.org/10.1016/S1368-8375(00)00063-4
Jensen, K., Bonde Jensen, A., & Grau, C. (2006). The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires. Radiotherapy and Oncology, 78(3), 298-305. https://doi.org/10.1016/j.radonc.2006.02.005
Kamal, M., Rosenthal, D. I., Volpe, S., Goepfert, R. P., Garden, A. S., Hutcheson, K. A., … Gunn, G. B. (2018). Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiotherapy and Oncology, 126(1), 75-80. https://doi.org/10.1016/j.radonc.2017.10.037
Lastrucci, L., Bertocci, S., Bini, V., Borghesi, S., De Majo, R., Rampini, A., … Pernici, P. (2018). Xerostomia Quality of Life Scale (XeQoLS) questionnaire: Validation of Italian version in head and neck cancer patients. La Radiologia Medica, 123(1), 44-47. https://doi.org/10.1007/s11547-017-0798-7
Lin, A., Kim, H. M., Terrell, J. E., Dawson, L. A., Ship, J. A., & Eisbruch, A. (2003). Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study. International Journal of Radiation Oncology Biology Physics, 57(1), 61-70. https://doi.org/10.1016/S0360-3016(03)00361-4
Lin, S.-C., Jen, Y.-M., Chang, Y.-C., & Lin, C.-C. (2008). Assessment of Xerostomia and Its Impact on Quality of Life in Head and Neck Cancer Patients Undergoing Radiotherapy, and Validation of the Taiwanese Version of the Xerostomia Questionnaire. Journal of Pain and Symptom Management, 36(2), 141-148. https://doi.org/10.1016/j.jpainsymman.2007.09.009
Meirovitz, A., Murdoch-Kinch, C. A., Schipper, M., Pan, C., & Eisbruch, A. (2006). Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. International Journal of Radiation Oncology Biology Physics, 66(2), 445-453. https://doi.org/10.1016/j.ijrobp.2006.05.002
Memtsa, P. T., Tolia, M., Tzitzikas, I., Bizakis, I., Pistevou-Gombaki, K., Charalambidou, M., … Kyrgias, G. (2017). Validity and reliability of the Greek version of the xerostomia questionnaire in head and neck cancer patients. Supportive Care in Cancer, 25(3), 847-853. https://doi.org/10.1007/s00520-016-3471-0
Mokkink, L., De Vet, H., Prinsen, C., Patrick, D., Alonso, J., Bouter, L., & Terwee, C. (2018). COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures. Quality of Life Research, 27(5), 1171-1179. https://doi.org/10.1007/s11136-017-1765-4
Mokkink, L. B., Terwee, C. B., Knol, D. L., Stratford, P. W., Alonso, J., Patrick, D. L., … de Vet, H. (2006). Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement INstruments. BMC Medical Research Methodology, 6, 2-2. https://doi.org/10.1186/1471-2288-6-2
Mokkink, L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. L., … de Vet, H. C. W. (2010). The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. Journal of Clinical Epidemiology, 63(7), 737-745. https://doi.org/10.1016/j.jclinepi.2010.02.006
Ojo, B., Genden, E. M., Teng, M. S., Milbury, K., Misiukiewicz, K. J., & Badr, H. (2012). A systematic review of head and neck cancer quality of life assessment instruments. Oral Oncology, 48(10), 923-937. https://doi.org/10.1016/j.oraloncology.2012.03.025
Pellegrino, F., Groff, E., Bastiani, L., Fattori, B., & Sotti, G. (2015). Assessment of radiation-induced xerostomia: Validation of the Italian version of the xerostomia questionnaire in head and neck cancer patients. Supportive Care in Cancer, 23(4), 925-932. https://doi.org/10.1007/s00520-014-2438-2
Prinsen, C. A. C., Mokkink, L. B., Bouter, L. M., Alonso, J., Patrick, D. L., de Vet, H. C. W., & Terwee, C. B. (2018). COSMIN guideline for systematic reviews of patient-reported outcome measures. Quality of Life Research, 27(5), 1147-1157. https://doi.org/10.1007/s11136-018-1798-3
Ringash, J., Bernstein, L. J., Cella, D., Logemann, J., Movsas, B., Murphy, B., … Ridge, J. (2015). Outcomes toolbox for head and neck cancer research. Head and Neck, 37(3), 425-439. https://doi.org/10.1002/hed.23561
Terwee, C. B., Jansma, E. P., Riphagen, I. I., & de Vet, H. C. (2009). Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Quality of Life Research, 18(8), 1115-1123. https://doi.org/10.1007/s11136-009-9528-5
Terwee, C. B., Mokkink, L. B., Knol, D. L., Ostelo, R. W. J. G., Bouter, L. M., & Vet, H. C. W. (2011). Rating the methodological quality in systematic reviews of studies on measurement properties: A scoring system for the COSMIN checklist. Quality of Life Research, 21(4), 651-657. https://doi.org/10.1007/s11136-011-9960-1
Terwee, C. B., Prinsen, C. A. C., Chiarotto, A., Westerman, M. J., Patrick, D. L., Alonso, J., … Mokkink, L. B. (2018). COSMIN methodology for evaluating the content validity of patient-reported outcome measures: A Delphi study. Quality of Life Research, 27(5), 1159-1170. https://doi.org/10.1007/s11136-018-1829-0
Thomson, W. M. (2007). Measuring change in dry-mouth symptoms over time using the Xerostomia Inventory. Gerodontology, 24(1), 30-35. https://doi.org/10.1111/j.1741-2358.2007.00137.x
Thomson, W. M., & Williams, S. M. (2000). Further testing of the xerostomia inventory. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, 89(1), 46-50. https://doi.org/10.1016/S1079-2104(00)80013-X
Trotti, A., & Eisbruch, A. (2011). Reducing xerostomia through advanced technology. The Lancet Oncology, 12(2), 110-111. https://doi.org/10.1016/S1470-2045(11)70009-2

Auteurs

Motaz Assas (M)

Department of Fundamental and Clinical Dental Science, Faculty of Dentistry, Umm Al Qura University, Makkah, Saudi Arabia.
Department of Oral Medicine, Eastman Dental Institute, UCL, London, UK.

Paswach Wiriyakijja (P)

Department of Oral Medicine, Eastman Dental Institute, UCL, London, UK.
Department of Oral Medicine, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand.

Stefano Fedele (S)

Department of Oral Medicine, Eastman Dental Institute, UCL, London, UK.
National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK.

Stephen Porter (S)

Department of Oral Medicine, Eastman Dental Institute, UCL, London, UK.

Richeal Ní Ríordáin (R)

Department of Oral Medicine, Eastman Dental Institute, UCL, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH